320 related articles for article (PubMed ID: 20122449)
21. Short term impact of Tribulus terrestris intake on doping control analysis of endogenous steroids.
Saudan C; Baume N; Emery C; Strahm E; Saugy M
Forensic Sci Int; 2008 Jun; 178(1):e7-10. PubMed ID: 18282674
[TBL] [Abstract][Full Text] [Related]
22. [Doping--also a problem in general practice?].
Dickhuth HH; Berg A; Baumstark M; Rokitzki L; Huonker M; Keul J
Fortschr Med; 1989 Sep; 107(28):585-8. PubMed ID: 2613151
[TBL] [Abstract][Full Text] [Related]
23. [Anabolic steroids and their abuse in sports].
Bruno M
Clin Ter; 1990 Nov; 135(3):159-72. PubMed ID: 2150017
[TBL] [Abstract][Full Text] [Related]
24. IRMS delta values (
Brailsford AD; Majidin WNM; Wojek N; Cowan DA; Walker C
Drug Test Anal; 2018 Nov; 10(11-12):1722-1727. PubMed ID: 30381908
[TBL] [Abstract][Full Text] [Related]
25. Searching for new markers of endogenous steroid administration in athletes: "looking outside the metabolic box".
Cawley AT; Hine ER; Trout GJ; George AV; Kazlauskas R
Forensic Sci Int; 2004 Jul; 143(2-3):103-14. PubMed ID: 15240029
[TBL] [Abstract][Full Text] [Related]
26. Doping control analysis of tricyclic tetrahydroquinoline-derived selective androgen receptor modulators using liquid chromatography/electrospray ionization tandem mass spectrometry.
Thevis M; Kohler M; Thomas A; Schlörer N; Schänzer W
Rapid Commun Mass Spectrom; 2008 Aug; 22(16):2471-8. PubMed ID: 18634123
[TBL] [Abstract][Full Text] [Related]
27. Nandrolone: a multi-faceted doping agent.
Hemmersbach P; Grosse J
Handb Exp Pharmacol; 2010; (195):127-54. PubMed ID: 20020363
[TBL] [Abstract][Full Text] [Related]
28. Impaired vasoreactivity in bodybuilders using androgenic anabolic steroids.
Lane HA; Grace F; Smith JC; Morris K; Cockcroft J; Scanlon MF; Davies JS
Eur J Clin Invest; 2006 Jul; 36(7):483-8. PubMed ID: 16796605
[TBL] [Abstract][Full Text] [Related]
29. Anabolic steroids: a fatal attraction?
Wood RI
J Neuroendocrinol; 2006 Mar; 18(3):227-8. PubMed ID: 16454806
[TBL] [Abstract][Full Text] [Related]
30. Determination of 13C/12C ratios of endogenous urinary steroids: method validation, reference population and application to doping control purposes.
Piper T; Mareck U; Geyer H; Flenker U; Thevis M; Platen P; Schänzer W
Rapid Commun Mass Spectrom; 2008 Jul; 22(14):2161-75. PubMed ID: 18536069
[TBL] [Abstract][Full Text] [Related]
31. Anabolic steroid use in adolescents: identification of those at risk and strategies for prevention.
Mulcahey MK; Schiller JR; Hulstyn MJ
Phys Sportsmed; 2010 Oct; 38(3):105-13. PubMed ID: 20959703
[TBL] [Abstract][Full Text] [Related]
32. [Dangers and risks of black market anabolic steroid abuse in sports --gas chromatography-mass spectrometry analyses].
Ritsch M; Musshoff F
Sportverletz Sportschaden; 2000 Mar; 14(1):1-11. PubMed ID: 10859788
[TBL] [Abstract][Full Text] [Related]
33. Anabolic steroids in sport.
VanHelder WP; Kofman E; Tremblay MS
Can J Sport Sci; 1991 Dec; 16(4):248-57. PubMed ID: 1663826
[TBL] [Abstract][Full Text] [Related]
34. The application of carbon isotope ratio mass spectrometry to doping control.
Cawley AT; Flenker U
J Mass Spectrom; 2008 Jul; 43(7):854-64. PubMed ID: 18523972
[TBL] [Abstract][Full Text] [Related]
35. Anabolic-androgenic steroids: use and abuse in pediatric patients.
Kerr JM; Congeni JA
Pediatr Clin North Am; 2007 Aug; 54(4):771-85, xii. PubMed ID: 17723876
[TBL] [Abstract][Full Text] [Related]
36. Reference ranges for urinary concentrations and ratios of endogenous steroids, which can be used as markers for steroid misuse, in a Caucasian population of athletes.
Van Renterghem P; Van Eenoo P; Geyer H; Schänzer W; Delbeke FT
Steroids; 2010 Feb; 75(2):154-63. PubMed ID: 19962394
[TBL] [Abstract][Full Text] [Related]
37. Effects of propyphenazone and other non-steroidal anti-inflammatory agents on the synthetic and endogenous androgenic anabolic steroids urinary excretion and/or instrumental detection.
Mazzarino M; Braganò MC; Donati F; de la Torre X; Botrè F
Anal Chim Acta; 2010 Jan; 657(1):60-8. PubMed ID: 19951758
[TBL] [Abstract][Full Text] [Related]
38. Determination of the origin of urinary norandrosterone traces by gas chromatography combustion isotope ratio mass spectrometry.
Hebestreit M; Flenker U; Fusshöller G; Geyer H; Güntner U; Mareck U; Piper T; Thevis M; Ayotte C; Schänzer W
Analyst; 2006 Sep; 131(9):1021-6. PubMed ID: 17047802
[TBL] [Abstract][Full Text] [Related]
39. Performance-enhancing substances in adolescent athletes.
Gomez JE
Tex Med; 2002 Feb; 98(2):41-6. PubMed ID: 11862891
[TBL] [Abstract][Full Text] [Related]
40. Analysis of exogenous dehydroepiandrosterone excretion in urine by gas chromatography/combustion/isotope ratio mass spectrometry.
Ueki M; Okano M
Rapid Commun Mass Spectrom; 1999; 13(22):2237-43. PubMed ID: 10547630
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
